UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Terminated
Unique ID issued by UMIN UMIN000032026
Receipt No. R000032697
Scientific Title The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by multi-kinase inhibitors sorafenib.
Date of disclosure of the study information 2018/03/30
Last modified on 2019/04/04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by multi-kinase inhibitors sorafenib.
Acronym The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by multi-kinase inhibitors sorafenib.
Scientific Title The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by multi-kinase inhibitors sorafenib.
Scientific Title:Acronym The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by multi-kinase inhibitors sorafenib.
Region
Japan

Condition
Condition Hepastocellular cancer(HCC)
Classification by specialty
Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The development of new preventive measures and therapeutic methods using alminium chloride in the management of hand-foot syndrome by multi-kinase inhibitors.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Incidence of Grade 3 HFS
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 12 weeks /Application of aluminium chloride ointment once a day
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria 1)Cancer patients who are scheduled to be on Sorafeniv.
2)Patients who are scheduled to be on the drugs with standard dosage
3) PS0-1
4) Written informed consent for this study can be obtained from the patients.
Key exclusion criteria 1) Patients with fissure or erosion in the palmoplantar area
2) Patients with a history of sympathectomy
Target sample size 16

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Aya Nishizawa
Organization National Defense Medical College
Division name Dermatology
Zip code
Address 3-2 Namiki, Tokorozawa, Saiama 359-8513
TEL 04-2995-1665
Email ayanishiza@yahoo.co.jp

Public contact
Name of contact person
1st name
Middle name
Last name Aya Nishizawa
Organization National Defense Medical College
Division name Dermatology
Zip code
Address 3-2 Namiki, Tokorozawa, Saiama 359-8513
TEL 04-2995-1665
Homepage URL
Email ayanishiza@yahoo.co.jp

Sponsor
Institute National Defense Medical College
Institute
Department

Funding Source
Organization Grants-in-Aid for Sientific Research
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 03 Month 30 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2017 Year 11 Month 24 Day
Date of IRB
2017 Year 11 Month 24 Day
Anticipated trial start date
2017 Year 11 Month 24 Day
Last follow-up date
2017 Year 11 Month 24 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2018 Year 03 Month 30 Day
Last modified on
2019 Year 04 Month 04 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032697

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.